Rebekah J. Dickmander

发表

Host kinase CSNK2 is a target for inhibition of pathogenic β-coronaviruses including SARS-CoV-2

T. Willson, R. Baric, M. Heise, 2022, bioRxiv.

Host Kinase CSNK2 is a Target for Inhibition of Pathogenic SARS-like β-Coronaviruses

T. Willson, R. Baric, M. Heise, 2022, ACS chemical biology.

Vandetanib Blocks the Cytokine Storm in SARS-CoV-2-Infected Mice

S. Ekins, R. Baric, K. Pearce, 2022, ACS omega.

Identification and Utilization of a Chemical Probe to Interrogate the Roles of PIKfyve in the Lifecycle of β-Coronaviruses

M. Heise, D. Drewry, P. McPherson, 2022, Journal of medicinal chemistry.

TARGETED DOWN REGULATION OF CORE MITOCHONDRIAL GENES DURING SARS-COV-2 INFECTION

Larry N. Singh, Amanda M. Saravia-Butler, Yared H. Kidane, 2022, bioRxiv.

Vandetanib Reduces Inflammatory Cytokines and Ameliorates COVID-19 in Infected Mice

S. Ekins, K. Pearce, A. Fabro, 2021, bioRxiv.

Optimization of 3-Cyano-7-cyclopropylamino-pyrazolo[1,5-a]pyrimidines Toward the Development of an In Vivo Chemical Probe for CSNK2A

T. Willson, A. Axtman, Nathaniel J. Moorman, 2023, bioRxiv.

Core mitochondrial genes are down-regulated during SARS-CoV-2 infection of rodent and human hosts

Larry N. Singh, Amanda M. Saravia-Butler, Yared H. Kidane, 2023, Science Translational Medicine.

Lethal COVID-19 Associates With RAAS-Induced Inflammation For Multiple Organ Damage Including Mediastinal Lymph Nodes

M. Heise, M. Emmett, A. Beheshti, 2023, bioRxiv.

Strategic Fluorination to Achieve a Potent, Selective, Metabolically Stable, and Orally Bioavailable Inhibitor of CSNK2

R. Couñago, D. Drewry, S. Taft-Benz, 2024, Molecules.

More than an Amide Bioisostere: Discovery of 1,2,4-Triazole-containing Pyrazolo[1,5-a]pyrimidine Host CSNK2 Inhibitors for Combatting β-Coronavirus Replication

Tammy M. Havener, R. Couñago, D. Drewry, 2024, Journal of medicinal chemistry.